Denmark· DK-28105993315
Erelzi
A etanercept product containing etanercept, registered in Denmark by Sandoz GmbH. The same ATC class is registered in 14 of our 19 countries.
Checked against Danish Medicines Agency (Denmark) on
Informational only — not a medical device.
Where it is registered
Etanercept is registered in 14 of 19 countries.
Countries holding a registration under ATC L04AB01 (etanercept), each read from that country’s own register.
- This record: Denmark, from Danish Medicines Agency (Denmark)
- 9 of them publish a price we can compare per daily dose
Etanercept · ATC L04AB01
14 / 19 countries
- Belgiumprice
- Canada
- Czechiaprice
- Denmark
- Finlandprice
- Franceprice
- Icelandprice
- Ireland
- Netherlands
- Norwayprice
- Polandprice
- Switzerlandprice
- United Kingdom
- United Statesprice
Price per daily dose
What a daily dose of etanercept costs, country by country.
Normalised to the WHO defined daily dose (7 mg), the median price runs from $0.35 in Finland to $35.22 in Switzerland — a ×100 gap.
- 2 markets with a comparable price for this class
- Public list prices, converted to USD at the rate date shown
Etanercept · price per daily dose (7 mg)
USD · FX 28 Sept 2026
- CH Switzerland$35.22
- FI Finland$0.35
The record
At a glance
Danish Medicines Agency (Denmark)- Active substance
- ETANERCEPT
- Manufacturer
- Sandoz GmbH
- Country
- Denmark (DK)
- ATC code
- L04AB01
- ATC class
- Etanercept
- Defined daily dose
- 7 mg, P
- Reimbursed
- Not published by this register
- Source register
- Danish Medicines Agency (Denmark)
- Last checked
- September 30, 2026
Packs & prices · 1
- dk_varenummer28105993315
Regulatory notes
No shortage, Orange Book or US label notes for this record.
Interactions
429 interactions on record for etanercept.
Graded by severity as the source publishes them — 287 severe. Severity grades are free for everyone; mechanism and management come with Growth.
- Severity for every pair — free, no plan needed
- The source, licence and sync date on every record
- Mechanism and what to do for each pair — Growth plan
Etanercept · interactions on record
429 records
- 287 severe
- 135 moderate
- 7 minor
Most severe, free to view
- PrednisoloneA07EA01severe
- HydrocortisoneA07EA02severe
- PrednisoneA07EA03severe
- BetamethasoneA07EA04severe
- Interaction severity from DDInter 2.0 (Xiong G. et al., Nucleic Acids Res.), licensed CC BY-NC 4.0 — free for non-commercial use only; not covered by the Drug Database commercial licence.
Same class
Other records under L04AB01
Etanercept, as other registers publish it.
- DenmarkBenepaliSamsung Bioepis NL B.V.
- IcelandBenepaliSamsung Bioepis NL B.V.
- FinlandBenepaliSAMSUNG BIOEPIS NL B.V.
- FinlandBenepaliSAMSUNG BIOEPIS NL B.V.
- NorwayBenepaliSamsung Bioepis NL B.V.
- PolandBenepaliSamsung Bioepis NL B.V.
- FinlandBenepaliSAMSUNG BIOEPIS NL B.V.
- IcelandBenepaliSamsung Bioepis NL B.V.
Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of Danish Medicines Agency (Denmark). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.
For developers
The same record over the API, and the raw payload
GET /v1/drugs/f9bc8b09-a9f5-4a64-b02c-862efd630cae GET /v1/drugs/f9bc8b09-a9f5-4a64-b02c-862efd630cae?format=fhir
Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.
{
"form": "injektionsvæske, opløsning i fyldt pen",
"source": "dkma",
"strength": "50 mg",
"auth_role": "MOD",
"dk_drugid": "28105993315",
"substance": "ETANERCEPT",
"auth_procedure": "Central",
"in_medicinpriser": true,
"registration_date_serial": "42909"
}See everything about etanercept.
This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.